medigraphic.com
ISSN 2221-2434 (Electronic)

2016, Number 1

<< Back Next >>

Finlay 2016; 6 (1)

Chondrocalcinosis (pseudogout): a frequently underdiagnosed disorder. A case report and literature review

Hernández MAD, Puerto NI, Falcón HA

Language: Spanish
References: 30
Page: 59-65
PDF size: 165.82 Kb.


ABSTRACT

Chondrocalcinosis or calcium pyrophosphate dihydrate crystal deposition disease refers to the clinical and radiographic manifestations resulting from the presence of calcium pyrophosphate in the cartilaginous structures of the joints. This disease usually has a chronic course and is associated with other conditions such as diabetes mellitus, hypertension, hyperparathyroidism, hyperuricemia and most often, osteoarthritis. We present the case of a patient with a history of osteoarthritis who attended consultation due to acute polyarticular joint pain that had been present for approximately a month. During her follow-up, the diagnosis of chondrocalcinosis was established. The patient recovered gradually after treatment, which allowed her to resume her daily activities. This report presents the importance of early diagnosis and treatment of this chronic evolution that is rarely diagnosed.


REFERENCES

  1. Rotés J, Muñoz J. Enfermedades reumáticas. Barcelona: Editorial Toray; 1971

  2. Snaith ML. ABC of rheumatology. Gout, hyperuricaemia, and crystal arthritis. BMJ. 1995;310(6978):521-4

  3. Resnick D, Niwayama G. Calcium pyrophosphate dihydrate (CCPD) crystal deposition disease. En: Saunders WB. Diagnosis of bone and joint disorders. Philadelphia: Saunders Company; 1995: p. 1556-614

  4. Thouverey C, Bechkoff G, Pikula S, Buchet R. Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles. Osteoarthritis Cartilage. 2009;17(1):64-72

  5. Andrés M, Paloma V. Tratamiento de la enfermedad por cristales de pirofosfato cálcico. Sem Fun Esp Reumatol. 2010;11(4):1-10

  6. Touraine S, Ea HK, Bousson V, Cohen M, Laouisset L, Chappard C, et al. Chondrocalcinosis of femoro-tibial and proximal tibio-fibular joints in cadaveric specimens: a high-resolution CT imaging study of the calcification distribution. PLoS One. 2013;8(1):e54955

  7. Fuerst M. Chondrokalzinose. Klinische bedeutung von intraartikulären kalziumphosphatkristallen. Z Rheumatol. 2014;73(5):415-9

  8. Bencardino JT, Hassanknani A. Calcium pyrophosphate dihydrate crystal deposition disease. Sem Mus Radiol. 2003;7(3):61-89

  9. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 1992;22(3):188-202

  10. Timms AE, Zhang Y, Rusell RG, Brown MA. Genetic studies of disorders of calcium crystal deposition. Rheumatology (Oxford). 2002;41(7):725-9

  11. Fuerst M, Lammers L, Schäfer F, Niggemeyer O, Steinhagen J, Lohmann CH, et al. Investigation of calcium crystals in OA knees. Rheumatol Int. 2010;30(5):623-31

  12. Derfus BA, Kurian JB, Butler JJ, Daft LJ, Carrera GF, Ryan LM, et al. The high prevalence of pathologic calcium crystals in pre-operative knees. J Rheumatol. 2002;29(3):570-4

  13. Fuerst M, Bertrand J, Lammers L, Dreier R, Echtermeyer F, Nitschke Y, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum. 2009;60(9):2694-703

  14. Fernández MP, Gómez JJ. Familial chondrocalcinosis in the Spanish population. J Rheumatol. 1986;13(3):631-3

  15. Zhang Y, Brow A. Genetic studies of chondrocalcinosis. Curr Opin Rheumatol. 2005;17(3):330-5

  16. Ryan LM, Rosenthal AK. Metabolism of extracelular pyrophosphate. Curr Opin Rheumatol. 2003;15(3):311-4

  17. Ea HK, Lioté F. Diagnosis and clinical manifestations of calcium pyrophosphate and basic calcium phosphate crystal deposition diseases. Rheum Dis Clin North Am. 2014;40(2):207-29

  18. Zitnan D, Sitaj S. Chondrocalcinosis articularis. Clinical and radiological study. Ann Rheum Dis. 1963;22(3):142-52

  19. Wright GD, Doherty M. Calcium pyrophosphate crystal deposition is not always ‘wear and tear’ or aging. Ann Rheum Dis. 1997;56(10):586-8

  20. Tausche AK, Aringer M. Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis. Z Rheumatol. 2014;73(4):349-57

  21. Yang BY, Sartoris BJ, Djukic S, Resnick D, Clopton P. Distribution of calcification in the triangular fibrocartilage region in 181 patients with calcium pyrophosphate dihydrate crystal deposition disease. Radiology. 1995;196(2):547-50

  22. Filippucci E, Di Geso L, Girolimetti R, Grassi W. Ultrasound in crystal-related arthritis. Clin Exp Rheumatol. 2014;32(1 Suppl 80):S42-7

  23. Vergara J, Díaz MR, Ortega A, Blanco JA, Hernández JM, Herrera A, et al. Protocolo de valoración de la patología de la rodilla. Semergen. 2004;30(5):178-87

  24. Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Leeb FB, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70(1):563-70

  25. Cavallaro GC. Patología médica para fisioterapeutas. Madrid: Editorial Médica Panamericana; 2001

  26. Garrison SJ. Manual de Medicina Física y Rehabilitación. 2da. ed. Madrid: Editorial McGraw-Hill Interamericana; 2005

  27. Serra MR, Díaz J, Sande ML. Fisioterapia en traumatología, ortopedia y reumatología. Barcelona: Editorial Springer- Yerlag Ibérica SA; 1997

  28. Sáez L. Tratamiento de fisioterapia en pacientes con condrocalcinosis. Rev Fisioter. 2006;5(2):37-44

  29. Instituto Nacional de Artritis y Enfermedades Musculoesqueléticas y de la Piel. Cirugía de reemplazo articular: Información básica de salud para usted y su familia [Internet]. 2014 [citado 24 Mar 2015]. Disponible en: http://www.niams.nih.gov/portal_en_espanol/infor macion_de_salud/cirugia_de_reemplazo_articular/ default.asp

  30. Zaka R, Williams CH. Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol. 2006;18(2):181-6




2020     |     www.medigraphic.com